Praxis Precision Medicines
PRAX
PRAX
108 hedge funds and large institutions have $95.6M invested in Praxis Precision Medicines in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
9% less capital invested
Capital invested by funds: $106M → $95.6M (-$9.9M)
Holders
108
Holding in Top 10
2
Calls
$541K
Puts
–
Top Buyers
| 1 | +$2.92M | |
| 2 | +$1.6M | |
| 3 | +$1.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.13M |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$940K |
Top Sellers
| 1 | -$9.59M | |
| 2 | -$1.67M | |
| 3 | -$814K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$756K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$655K |